Third Rock Ventures is a venture capital firm with offices in Boston and San Francisco. Founded in 2007, the firm invests in biotechnology startups.
Third Rock Ventures has raised $3.8 billion since it was created andÃÂ invested in more than 60 companies, including Sage Therapeutics, Editas Medicine, Constellation Pharmaceuticals and Flare Therapeutics.